查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球生化分析儀市場
市場調查報告書
商品編碼
1176599

2023-2030 年全球生化分析儀市場

Global Biochemistry Analyzers Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內 (2023-2030)，生化分析儀的全球市場規模預計將以 6.2% 的複合年增長率增長。

生化分析儀是一種採集血液或尿液，使用試劑引起反應，並測量糖和膽固醇等各種成分的設備。 這些測試在常規健康檢查和醫院進行。 結果，可以獲得指示疾病的早期檢測和診斷、治療效果和患者預後的客觀數據。

市場動態

由於糖尿病等慢性病患者的增加、診斷服務的分散化、對POC解決方案的需求增加以及新興市場對醫療基礎設施的投資增加，生化分析儀的市場正在擴大。

診斷服務的分散化和對醫療保健基礎設施投資的增加預計將推動市場的增長。

由於技術進步、對 POC 解決方案的需求增加、研發投資激增、糖尿病等慢性病的增加以及新興市場醫療基礎設施的進步，生化分析儀市場正在使用最新技術實現新的增長。產品改進。 慢性病影響著全世界數百萬人，據說僅糖尿病一項就影響了 4.22 億人。 隨著全球受這些疾病影響的人數增加，對診斷測試的需求也將增加。

技術進步使生化分析儀變得更快、更小。 便攜式、緊湊型生化分析儀的可用性不斷提高，使醫生能夠建立即時診斷中心，而不是將樣本送到大型實驗室。

此外，床旁設備覆蓋的疾病數量也在增加，這可能會增加對緊湊型分析儀的需求。 由於這些因素，以及需要進行生化測試以確認多種疾病，政府和私營公司增加的醫療保健支出可能會導致對生化分析儀等基礎設施的投資增加。這是一種自然現象。

各種新產品的發布和研究正在為市場的增長做出貢獻。 例如，2022年5月13日，邁瑞宣布推出BS-600M化學分析儀。 這款功能強大且高效的分析儀專為中型實驗室開發，旨在提高效率、可靠性和生產力。 它結構緊湊，通量高，可實現連續樣品加載，提供穩健的性能、出色的精度和準確度以及成本效益。

與生化分析儀相關的高資本成本預計會阻礙市場增長。

全球生化分析儀市場涉及儀器資本成本高，部分地區保險報銷下降，以及復雜的系統集成，沒有分析儀使用經驗的人無法管理。設備。

生化分析儀的資金成本很高。 高端設備的成本高達 45,000 美元。 為此，醫院等用戶被迫租購，銷量不斷下降。

COVID-19 影響分析

疫情對全球金融預測、運營和危機應對策略產生了積極影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID，生化分析儀市場獲得了巨大收益。 病毒增加了肝損傷和呼吸系統疾病的發病率，導致對這些生化分析儀的需求增加。 主要製造商已經啟動了各種研究和臨床試驗。 全球範圍內正在發生多項舉措、產品發布、合作和合併，促進了市場增長。 例如，2021 年 11 月 3 日，醫療器械和解決方案的開發商和供應商邁瑞宣布與體外診斷公司 Randox 合作，提供新的生化參數。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 診斷服務的分散化
      • 擴大對醫療保健基礎設施的投資
      • 不斷進步的技術進步
    • 約束因素
      • 關於全自動生化分析儀相關的副作用
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 全自動生化分析儀
  • 半自動生化分析儀

第八章配置

  • 台式生化分析儀
  • 落地式生化分析儀

第9章容量

  • 緊湊型生化分析儀
  • 中型生化分析儀
  • 大型生化分析儀

第 10 章應用

  • 臨床診斷
  • 藥物開發
  • 通過生物反應器產物檢測
  • 其他

第 11 章最終用戶

  • 醫院
  • 診斷實驗室
  • 製藥和生物技術公司
  • 研究所
  • 其他

第12章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第13章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第14章公司簡介

  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Beckman Coulter, Inc.
  • Horiba Medical
  • Siemens Healthineers AG
  • Hitachi High-Tech Corporation
  • EKF Diagnostics
  • Thermo Fisher Scientific Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Randox Laboratories Ltd.
  • QuidelOrtho Corporation

第15章 ataM

簡介目錄
Product Code: DMLE1230

Market Overview

The global biochemistry analyzer market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.2% during the forecast period (2023-2030).

The biochemistry analyzer is an instrument that uses a blood or urine sample and induces reactions using reagents to measure various components, such as sugar, cholesterol, etc. These tests are performed for routine health checks or at hospitals. The results provide objective data enabling early detection and diagnosis of disease and indicating the effects of treatment and patient prognosis.

Market Dynamics

The market for biochemistry analyzers is driven by the increase in the number of people affected with chronic diseases such as diabetes, decentralization of diagnostics services, increase in demand for POC solutions and the rising investment in healthcare infrastructure in emerging markets.

The decentralization of diagnostic services and rising investment in healthcare infrastructure are expected to drive the market's growth.

The biochemistry analyzers market is driven by rising advancements in technology, an increase in demand for POC solutions, a surge in research and development investments, an increasing number of chronic disorders such as diabetes, and improvements in novel products using the latest technology along with advances in medical infrastructure in emerging markets. Chronic diseases affect millions worldwide, with diabetes alone affecting 422 million people. With the number of people affected by these disorders increasing worldwide, the demand for diagnostic tests could increase.

Technological advances have resulted in biochemistry analyzers becoming faster and smaller. The rising availability of portable and smaller biochemistry analyzers has made it possible for physicians to set up their point-of-care diagnostic centers instead of sending the samples to large labs.

The number of diseases covered by point-of-care devices is also rising, thus potentially increasing the demand for small analyzers. Along with these factors, due to the necessity of performing biochemistry tests to confirm multiple disorders, rising healthcare expenditure by governments and the private sector could lead to higher investments in infrastructure such as biochemistry analyzers.

Various novel product launches and research studies contribute to the market's growth. For instance, in 13 May 2022, Mindray announced the launch of its BS-600M chemistry analyzer. This powerful yet efficient analyzer was developed for the medium size laboratories to enhance efficiency, reliability and productivity. It is compact with high throughput that allows continuous sample loading and provides robust performance, excellent precision and accuracy and high-cost efficiency.

The high capital cost associated with biochemistry analyzers is expected to hamper the market's growth.

The global market for biochemistry analyzers is restrained by the high capital cost of the machines, reduction in insurance reimbursement in some regions and shortage of skilled labor for managing the analyzers as they have complex system integration and hence can't be managed by a person without any experience of using these biochemical analyzers.

Biochemistry analyzers have a significant capital cost; high-end machines may cost as much as $45000. These high capital costs force users such as hospitals to acquire them on rental plans leading to lower sales.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely affected the healthcare industry. The biochemistry analyzers market has experienced huge profits due to COVID, as the incidence of liver disorders and respiratory disorders increased due to the virus leading to the demand for these biochemistry analyzers. Key manufacturers have started various research and clinical trials. Multiple initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Nov 3, 2021, Mindray, medical devices and solutions developer and supplier, announced its partnership with in-vitro diagnostics company Randox to provide novel biochemistry parameters.

Segment Analysis

The fully automatic biochemistry analyzers-type segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The fully automatic biochemistry analyzers type segment is the highest market holder in the global biochemistry analyzers market. The global biochemistry analyzers market is segmented based on type, as fully automated and semi-automatic biochemistry analyzers. The fully automatic biochemistry analyzers segment is the largest market shareholder due to its inherent advantages over semi-automatic analyzers, increasing technological advancements and novel product launches.

The fully automatic biochemistry analyzer is that samples can be processed in single, batches or continuously. In this type of analyzer, the instrument completes the whole process automatically, from sample addition to results. It only requires the operator to put the sample on the analyzer at a specific position and start the program without manual intervention. It is convenient, less time taking, has fewer measurement errors and provides quick analysis. To maintain product differentiation, key players are introducing new technologies, such as integrated and modular clinical chemistry analyzers, which perform the work of multiple machines at a faster rate.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in July 22, 2020, Beckman Coulter announced that its novel PK7400 automated microplate system analyzer and its reagents had received U.S. Food and Drug Administration clearance. This analyzer can be utilized in blood donor centers and large laboratories. This system in this class provides high throughput for a single analyzer and processes around 300 samples per hour.

Geographical Analysis

North America holds the largest market share in the global biochemistry analyzers market.

North America dominates the global biochemistry analyzers market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively high pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure. The number of people affected with chronic disease is projected to rise to 629 million by 2045, as per the International Diabetes Federation. In the UK alone, 500 million biochemistry tests are performed yearly, with more than 50 % being for chronic diseases.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of the biochemistry analyzers in several clinical diagnostics and drug development, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the biochemistry analyzers market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in January 25, 2021, Beckman Coulter, a clinical diagnostics provider, launched its tabletop analyzer, DxH 560 AL, which will minimize the small or medium-sized laboratory's resources and time constraints. This analyzer is compact and utilizes about 30% less space, offers auto-loading functionality and closed-tube aspiration capabilities, upto 50 samples can be added continually, takes less time on manual tasks and offers security against blood-borne microbes.

Competitive Landscape

The biochemistry analyzers market is highly competitive with local and global companies' presence. F. Hoffman-La Roche Ltd, Beckman Coulter, Inc., Horiba Medical, Siemens Healthineers AG, Hitachi High-Tech Corporation, EKF Diagnostics, Thermo Fisher Scientific Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Randox Laboratories Ltd., QuidelOrtho Corporation and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in December 23, 2021, Quidel Corporation, a point-of-care diagnostic solution manufacturer, announced its acquisition agreement completion with Ortho Clinical Diagnostics Holdings plc, an in vitro diagnostics company, to form QuidelOrtho.

F. Hoffman-La Roche Ltd.

Overview: Roche is a healthcare company that provides in-vitro diagnostics and supplies innovative and transformative solutions in various crucial disease areas. It works in two divisions: Pharmaceuticals and diagnostics. It was established in 1896 and is headquartered in Basel, Switzerland.

Product Portfolio:

Cobas 8000 analyzer series: These biochemistry analyzers are modular analyzers that provide a high-volume workload of over 500 samples daily with more than 440 configurations and 280 reagent positions.

Key Development: In Mar 16, 2022, Roche Diagnostics announced its partnership with SRL Diagnostics to transform its Fortis Memorial Research Institute laboratory with the integrated analyzer series of Roche.

The global biochemistry analyzers market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Decentralization of diagnostic services
      • 4.1.1.2. Increasing investment in healthcare infrastructure
      • 4.1.1.3. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with Biochemistry Analyzers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Fully Automatic Biochemistry Analyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Semi-Automatic Biochemistry Analyzers

8. By Configuration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 8.1.2. Market Attractiveness Index, By Configuration
  • 8.2. Bench-Top Biochemistry Analyzers *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Floor-Standing Biochemistry Analyzers

9. By Capacity

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 9.1.2. Market Attractiveness Index, By Capacity
  • 9.2. Small-Sized Biochemistry Analyzers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Medium-Sized Biochemistry Analyzers
  • 9.4. Large-Sized Biochemistry Analyzers

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Clinical Diagnostics *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Drug Development
  • 10.4. Bioreactor Byproduct Detection
  • 10.5. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Diagnostic Labs
  • 11.4. Pharmaceutical and Biotechnology Companies
  • 11.5. Research Institutions
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. F. Hoffmann-La Roche Ltd *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Beckman Coulter, Inc.
  • 14.3. Horiba Medical
  • 14.4. Siemens Healthineers AG
  • 14.5. Hitachi High-Tech Corporation
  • 14.6. EKF Diagnostics
  • 14.7. Thermo Fisher Scientific Inc.
  • 14.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 14.9. Randox Laboratories Ltd.
  • 14.10. QuidelOrtho Corporation

LIST NOT EXHAUSTIVE

15. Global Biochemistry Analyzers Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Application
  • 15.3. Contact Us